Navigation Links
CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
Date:5/25/2012

MATTHEWS, N.C., May 25, 2012 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 18, 2012. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school for a number of years.

(Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b )

"I am honored to have been asked to deliver the commencement address again this year," said Michael J. Collins. "UT's encouragement of science and innovation has resulted in a thriving chemistry and biochemistry program whose graduates rank at the top of their professions. I enjoyed speaking to this year's graduates and I look forward to the scientific discoveries and contributions they will make in the years to come."

Collins told the audience about his time at the University of Texas at Austin and how it helped shape his life as a chemist, entrepreneur, and business leader. He advised graduates to disregard the defeatists that have been predicting a worsening of the economy and a lack of opportunities.

"I predict we are on the verge of a major new era of growth for the US which will exceed anything we have seen in the past," said Collins, who believes the growth will be driven by continuing technological advancements in many fields including medicine, material science, and energy production and the ongoing globalization of business as new markets open up in developing countries. 

Collins also sees a coming revitalization of American manufacturing through entrepreneurial innovation and breakthroughs in technology.

"Science-based technology companies will continue to change the world. Chemistry and biochemistry will drive many of these companies," said Collins. "Your goal is to go forward and truly become our greatest generation ever."

Collins encouraged the graduates to find something they are passionate about and to pursue it with all their energy and determination.

"Whatever you decide to do, be the absolute best at it and keep challenging yourself," Collins encouraged. "Always be prepared, but be bold and think big."

A prepared text of Dr. Collins' commencement address is available on CEM's website at www.cem.com.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. RIFM Board Names New President
2. Ultragenyx Appoints Shalini Sharp as Chief Financial Officer and Senior Vice President, Finance
3. Hospira Names John B. Elliot Senior Vice President of Operations
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
6. Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer
7. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
8. Fitzsimons Redevelopment Authority Names New President & CEO
9. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
10. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
11. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
Breaking Biology News(10 mins):